In India, a host of companies including GalxoSmithKline & Sun Pharma
sell over 180 versions of the drug.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ranitidine-under-lens-after-carcinogen-alert/articleshow/71286722.cms
No comments:
Post a Comment